BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

BrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q1 2020 Results - Earnings Call Tran
May 10, 2020 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q4 2019 Results - Earnings Call Tr
Feb. 18, 2020 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q3 2019 Results - Earnings Call Transcri
Nov. 14, 2019 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q2 2019 Results - Earnings Call Transcri
Aug. 13, 2019 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q3 2018 Results - Earnings Call Transcri
Oct. 29, 2018 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics Inc. (BCLI) CEO Chaim Lebovits on Q2 2018 Results - Earnings Call Tran
July 23, 2018 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q1 2018 Results - Earnings Call Transcri
May 14, 2018 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q4 2017 Results - Earnings Call Transcri
March 10, 2018 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q3 2017 Results - Earnings Call Transcri
Oct. 17, 2017 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Chaim Lebovits on Q2 2017 Results - Earnings Call Transcri
Aug. 16, 2017 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Tony Fiorino on Q4 2014 Results - Earnings Call Transcript
March 26, 2015 | Price: Free! | Source: Seeking Alpha

BrainStorm Cell Therapeutics' (BCLI) CEO Tony Fiorino on Q3 2014 Results - Earnings Call Transcript
Nov. 13, 2014 | Price: Free! | Source: Seeking Alpha

Recent filings

EVP of BRAINSTORM CELL THERAPEUTICS INC. just picked up 25,000 shares - June 1, 2020

EVP of BRAINSTORM CELL THERAPEUTICS INC. just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - June 1, 2020

just provided an update on activist position in BRAINSTORM CELL THERAPEUTICS INC. - May 8, 2020

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 8 – SUBSEQUE... - May 7, 2020

Sankesh Abbhi just provided an update on activist position in BRAINSTORM CELL THERAPEUTICS INC. - April 8, 2020

BRAINSTORM CELL THERAPEUTICS INC.'s EVP and COO just picked up 50,000 shares - April 7, 2020

BRAINSTORM CELL THERAPEUTICS INC. director just declared owning 56,667 shares of BRAINSTORM CELL THERAPEUTICS INC. - April 7, 2020

BRAINSTORM CELL THERAPEUTICS INC. director just declared owning 2,117,751 shares of BRAINSTORM CELL THERAPEUTICS INC. - April 7, 2020

BRAINSTORM CELL THERAPEUTICS INC.'s EVP and COO just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - April 7, 2020

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 4,657 shares - April 7, 2020

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 50,000 options - April 7, 2020

Departure of Directors or Certain - April 3, 2020

Departure of Directors or Certain - March 31, 2020

Sankesh Abbhi just provided an update on share ownership of BRAINSTORM CELL THERAPEUTICS INC. - March 18, 2020

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer was just granted 80,000 options - March 13, 2020

Departure of Directors or Certain - March 13, 2020

Brainstorm Cell Therapeutics Raises $10.0 Million In Common Stock Sale At $8.00 Per Share - March 6, 2020

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - March 6, 2020

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - March 6, 2020

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 35,885 shares - March 6, 2020

Entry into a Material Definitive - March 6, 2020

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: J.           Basi... - Feb. 18, 2020

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 5,071 shares - Feb. 14, 2020

BRAINSTORM CELL THERAPEUTICS INC.'s EVP and Chief Business Officer was just granted 13,333 options - Feb. 14, 2020

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 2,000 shares - Feb. 14, 2020

EVP of BRAINSTORM CELL THERAPEUTICS INC. just picked up 11,600 shares - Dec. 27, 2019

BRAINSTORM CELL THERAPEUTICS INC.'s Chief Commercial Officer just picked up 3,000 shares - Dec. 27, 2019

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 3,000 shares - Dec. 27, 2019

Submission of Matters to a Vote of Security - Dec. 11, 2019

just provided an update on activist position in BRAINSTORM CELL THERAPEUTICS INC. - Nov. 21, 2019

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 7 - DEFERRED... - Nov. 14, 2019

BRAINSTORM CELL THERAPEUTICS INC. releases salary data. CEO sees compensation rise 57% - Oct. 25, 2019

EVP of BRAINSTORM CELL THERAPEUTICS INC. just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - Sept. 9, 2019

Departure of Directors or Certain - Sept. 9, 2019

EVP of BRAINSTORM CELL THERAPEUTICS INC. just picked up 25,000 shares - Sept. 9, 2019

BRAINSTORM CELL THERAPEUTICS INC. Just Received a Notice of Effectiveness - Aug. 30, 2019

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 30, 2019

BRAINSTORM CELL THERAPEUTICS INC. director just cashed-in 13,332 options - Aug. 30, 2019

Registration statement under Securities Act of 1933 - Aug. 16, 2019

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 9 - SUBSEQUE... - Aug. 13, 2019

Notice of Exempt Offering of Securities, item 06b - Aug. 9, 2019

Entry into a Material Definitive - Aug. 2, 2019

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - Aug. 2, 2019

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks just picked up 31,185 shares - July 26, 2019

Departure of Directors or Certain - July 26, 2019

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - June 11, 2019

Entry into a Material Definitive - June 11, 2019

As was previously - May 13, 2019

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 9 - SUBSEQUENT ... - May 10, 2019

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: J.Basic and diluted ... - April 1, 2019

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: J.Basic and diluted ... - March 29, 2019

Regulation FD - March 12, 2019

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 35,885 shares - March 8, 2019

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 3,501 shares - Feb. 22, 2019

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 1,475 shares - Jan. 8, 2019

Securities to be offered to employees in employee benefit plans - Dec. 21, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just cashed-in 121,558 options - Dec. 21, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 3,667 shares - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 25,333 options - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s EVP and Chief Business Officer was just granted 13,333 options - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 2,000 shares - Nov. 30, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 8  -SUBSEQUENT ... - Oct. 29, 2018

BRAINSTORM CELL THERAPEUTICS INC. releases salary data. CEO sees compensation rise 81% - Oct. 10, 2018

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - Sept. 28, 2018

Registration statement under Securities Act of 1933 - Sept. 21, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s Chief Commercial Officer just disposed of 2,805 shares - Sept. 4, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks just picked up 31,185 shares - July 27, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 9 - SUB... - July 23, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Received a Notice of Effectiveness - June 29, 2018

Notice of Exempt Offering of Securities, item 06b - June 20, 2018

Registration statement under Securities Act of 1933 - June 8, 2018

Entry into a Material Definitive - June 7, 2018

BRAINSTORM CELL THERAPEUTICS INC. just filed a prospectus, suggesting it plans to soon issue some securities - June 7, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 1,249 shares - March 26, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 35,885 shares - March 26, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 5,000 shares - March 20, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 5,700 shares - March 20, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 5,700 shares - March 16, 2018

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: J. Basic... - March 8, 2018

BRAINSTORM CELL THERAPEUTICS INC. director just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - Feb. 5, 2018

Departure of Directors or Certain - Feb. 5, 2018

On January - Jan. 4, 2018

BRAINSTORM CELL THERAPEUTICS INC.'s CFO and Treasurer just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - Nov. 20, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s CFO and Treasurer just picked up 25,000 shares - Nov. 20, 2017

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 2,000 shares - Nov. 13, 2017

BRAINSTORM CELL THERAPEUTICS: Appoints Eyal Rubin As Chief Financial Officer - Nov. 3, 2017

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: A summary of the C... - Oct. 17, 2017

BRAINSTORM CELL THERAPEUTICS INC. releases salary data. CEO sees compensation rise 4% - Sept. 14, 2017

BRAINSTORM CELL THERAPEUTICS INC. director just picked up 2,500 shares - Aug. 31, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s EVP & Chief Business Officer just picked up 2,000 shares - Aug. 23, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s See Remarks just picked up 31,185 shares - July 26, 2017

Entry into a Material Definitive - July 26, 2017

BRAINSTORM CELL THERAPEUTICS: Brainstorm Awarded $16 Million Non-Dilutive Grant From Cirm In Support Of Phase 3 Clinical Trial Of Nurown - July 21, 2017

BRAINSTORM CELL THERAPEUTICS INC. director was just granted 12,000 options - July 17, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s EVP & Chief Business Officer just picked up 5,543 shares - July 17, 2017

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Quarterly Report: NOTE 1    -    GE... - May 15, 2017

BRAINSTORM CELL THERAPEUTICS INC. Just Filed Its Annual Report: K. Basic ... - March 29, 2017

BRAINSTORM CELL THERAPEUTICS: Brainstorm Strengthens Management Team With Appointment Of Ralph Z. Kern, Md, Mhsc As Chief Operating Officer And Chief Medical Officer - March 6, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just declared ownership of no shares of BRAINSTORM CELL THERAPEUTICS INC. - March 6, 2017

BRAINSTORM CELL THERAPEUTICS INC.'s COO and Chief Medical Officer just picked up 35,885 shares - March 6, 2017

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. VANGUARD GROUP INC 1,216,272 N/A March 31, 2020
2. VANGUARD GROUP INC 1,216,272 N/A March 31, 2020
3. VANGUARD GROUP INC 1,216,272 N/A March 31, 2020
4. VANGUARD GROUP INC 766,868 N/A Sept. 30, 2019
5. VANGUARD GROUP INC 766,868 N/A Sept. 30, 2019
6. VANGUARD GROUP INC 766,868 N/A Sept. 30, 2019
7. VANGUARD GROUP INC 691,746 N/A June 30, 2019
8. RENAISSANCE TECHNOLOGIES LLC 576,638 N/A March 31, 2020
9. SUSQUEHANNA INTERNATIONAL GROUP, LLP 413,200 N/A March 31, 2020
10. SUSQUEHANNA INTERNATIONAL GROUP, LLP 413,200 N/A March 31, 2020
11. SUSQUEHANNA INTERNATIONAL GROUP, LLP 413,200 N/A March 31, 2020
12. SUSQUEHANNA INTERNATIONAL GROUP, LLP 413,200 N/A March 31, 2020
13. SUSQUEHANNA INTERNATIONAL GROUP, LLP 413,200 N/A March 31, 2020
14. BlackRock Inc. 384,000 N/A March 31, 2020
15. GROUP ONE TRADING, L.P. 280,100 N/A March 31, 2020
16. GROUP ONE TRADING, L.P. 280,100 N/A March 31, 2020
17. GROUP ONE TRADING, L.P. 280,100 N/A March 31, 2020
18. RAYMOND JAMES & ASSOCIATES 200,950 N/A March 31, 2020
19. MILLENNIUM MANAGEMENT LLC 198,052 N/A March 31, 2020
20. SUSQUEHANNA INTERNATIONAL GROUP, LLP 183,809 N/A June 30, 2019
21. SUSQUEHANNA INTERNATIONAL GROUP, LLP 183,809 N/A June 30, 2019
22. SUSQUEHANNA INTERNATIONAL GROUP, LLP 183,809 N/A June 30, 2019
23. GEODE CAPITAL MANAGEMENT, LLC 169,585 N/A March 31, 2020
24. SUSQUEHANNA INTERNATIONAL GROUP, LLP 157,516 N/A Sept. 30, 2019
25. Citadel Advisors LLC 137,600 N/A March 31, 2020
26. BlackRock Inc. 134,484 N/A Sept. 30, 2019
27. BlackRock Inc. 134,484 N/A Sept. 30, 2019
28. BlackRock Inc. 134,484 N/A Sept. 30, 2019
29. BlackRock Inc. 134,484 N/A Sept. 30, 2019
30. BlackRock Inc. 134,484 N/A Sept. 30, 2019

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

140
 


Feedback